Skip to search formSkip to main contentSkip to account menu

Travatan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Purpose: To assess ocular surface changes in participants using latanoprost with benzalkonium chloride (Xalatan) and travoprost… 
2016
2016
Objective: To assess symptoms of ocular surface disease (OSD) in patients treated with a BAK-preserved Xalatan (Latanoprost) to… 
2011
2011
PURPOSE To determine the element that modulates benzalkonium chloride (BAC) toxicity by using a new electrophysiological method… 
2010
2010
Purpose: This study evaluated the cytotoxicity of five prostaglandin analog ophthalmic solutions on four ocular surface cell… 
2007
2007
Travoprost Z (Travatan® Z) ophthalmic solution has recently been approved for the reduction of elevated intraocular pressure (IOP… 
2006
2006
The aim of investigation was to study the effect of travatan on intraocular pressure (IOP) in patients with primary open-angle…